| CAS编号 | 中文名 | 英文名 | 分子式 | 分子量 | 熔点 | 沸点 |
| 4447-60-3 | 原甲酸三异丙酯 | 2-diisopropoxymethoxy-propane | C10H22O3 | 190.28 | | 64-65℃(1 |
| 44470-22-6 | | trihydrogen, (oc-6-11)-ruthenate(3-hexachloro- | | | | |
| 44470-26-0 | | dihydrogen, (oc-6-11)-ruthenate(2-hexachloro- | | | | |
| 444717-58-2 | 4,4',4’'-(苯-1,3,5-三基三(氧基))三邻苯二甲酸 | 4,4',4''-(Benzene-1,3,5-triyltris(oxy))triphthalic acid | C30H18O15 | 618.45 | | |
| 444722-95-6 | | cdk1/2 inhibitor ii, nu6102-cas 444722-95-6-calbiochem | C18H22N6O3S | 402.47 | | |
| 444723-13-1 | 4-[[[6-(环己基甲氧基)-9h-嘌呤-2-基]氨基] -n，n-二乙基苯甲酰胺 | nu6140 | C23H30N6O2 | 422.52 | | |
| 444726-88-9 | | 4-bromo-dl-phenylalanine methyl ester hcl | | | | |
| 444727-07-5 | | 4-bromo-2-chloro-dl-phenylalanine | | | | |
| 444727-13-3 | 叔-丁基 4-(3-溴-5-(三氟甲基)苯基)哌嗪-1-羧酸酯 | tert-butyl 4-(3-broMo-5-(trifluoroMethyl)phenyl)piperazine-1-carboxylate | C16H20BrF3N2O2 | 409.25 | | 428.7±45.0 °C(Predicted) |
| 444728-13-6 | 氯吡格雷杂质18 | clopidogrel impurity 18 | C15H15ClN2OS | 306.81 | | |
| 444728-15-8 | (R)-2-(2-氯苯基)-2-(6,7-二氢噻吩并[3,2-c]吡啶-5(4H)-基)乙酰胺 | (R)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetamide | C15H15ClN2OS | 306.81 | | |
| 444731-47-9 | 帕唑帕尼杂质3 | pazopanib impurity 3 | C20H21N7O2S | 423.49 | | |
| 444731-52-6 | 帕唑帕尼 | | C21H23N7O2S | 437.53 | | |
| 444731-72-0 | 6-氨基-2,3-二甲基-2h-吲唑 | 2,3-dimethyl-2h-indazol-6-amine | C9H11N3 | 161.2 | | 366.9°C |
| 444731-73-1 | 2,3-二甲基-6-硝基吲唑 | 2,3-dimethyl-6-nitro-2h-indazole | C9H9N3O2 | 191.19 | | 377.033ºC |
| 444731-74-2 | n-(2-氯嘧啶-4-基)-2,3-二甲基-2h-吲唑-6-胺 | 6-[n-(2-chloropyrimidin-4-yl)amino]-2,3-dimethyl-2h-indazole | C13H12ClN5 | 273.7209 | | |
| 444731-75-3 | 6-[n-(2-氯-4-嘧啶基)甲基氨基]-2,3-二甲基-2h-吲唑 | 6-[n-(2-chloro-4-pyrimidinyl)methylamino]-2,3-dimethyl-2h-indazole | C14H14ClN5 | 287.75 | | 524.447°C at 760 mmHg |
| 444753-23-5 | (5S)-5-[4-(Benzyloxy)benzyl]-4-(tert-butoxycarbonyl)morpholin-3-one | | C23H27NO5 | 397.471 | | 569.6±45.0 °C(Predicted) |
| 444771-51-1 | | ethyl ((3z)-3-{[(2,4-dichlorophenoxy)acetyl]hydrazono}-2-oxo-2,3-dihydro-1h-indol-1-yl)acetate | | | | |
| 444777-18-8 | | 2-methyl-1,3-benzoxazole-5-carbonyl chloride | | | | |
| 444777-27-9 | 4,5-二氢呋喃-2-羧酸 | 4,5-dihydrofuran-2-carboxylic acid | | | | |
| 444777-67-7 | | h-d-phe(4-no2)-oh.h2o | C9H12N2O5 | 228.20 | | |
| 444794-69-8 | 6-[2-[(9h-芴-9-甲氧基)羰基]肼基]-3-吡啶羧酸 | 6-(2-(((9h-fluoren-9-yl)methoxy)carbonyl)hydrazinyl)nicotinic acid | C21H17N3O4 | 375.38 | | |
| 444796-09-2 | 2,7-二溴-9-苯基咔唑 | 2,7-dibromo-9-phenylcarbazole | C18H11Br2N | 401.1 | | |
| 4448-75-3 | 环庚甲醇 | (Hydroxymethyl)cycloheptane | C8H16O | 128.212 | | 215.1 °C at 760 mmHg |
| 4448-77-5 | | cycloheptanemethylamine | C8H17N | 127.22 | | 98-101 °C |
| 4448-84-4 | | (2-cycloheptylethyl)amine | C9H19N | 141.25 | | |
| 4448-96-8 | | 7-(2-(4-(o-methoxyphenyl)-1-piperazinyl)ethyl)(5h)-1,3-dioxole(4,5-f)ind ole | | | | |
| 444805-28-1 | Brincidofovir (CMX-001) | | C27H52N3O7P | 561.7 | | |
| 444807-47-0 | | methyl 2-(4-cyanophenyl)-2-methylpropanoate | C12H13NO2 | 203.09 | | |
| 444807-50-5 | 2-(4-氰基-3-氟苯基)乙酸甲酯 | Methyl 2-(4-cyano-3-fluorophenyl)acetate | C10H8FNO2 | 193.1744 | | |
| 444807-63-0 | 4-(氨基甲基)-3-氟苯酚盐酸盐 | 4-(Aminomethyl)-3-fluorophenolhydrochloride | C7H9ClFNO | 177.6 | | |
| 444808-24-6 | | (2e)-3-(4-tert-butylphenyl)-1-(2,4-dichlorophenyl)prop-2-en-1-one | | | | |
| 444814-24-8 | (5R)-5-(氯甲基)-3-[(1R)-1-苯乙基]-2-噁唑烷酮 | (4S)-4-(chloromethyl)-3-[(1R)-1-phenylethyl]-2-oxazolidinone | | | | |
| 444814-32-8 | (4R)-4-(氯甲基)-3-[(1R)-1-苯乙基]-2-噁唑烷酮 | (4R)-4-(chloromethyl)-3-[(1R)-1-phenylethyl]-2-oxazolidinone | | | | |
| 444815-08-1 | | 1-[3-(aminomethyl)phenyl]piperidin-2-one | | | | |
| 444885-09-0 | (2-甲基丁基)硼酸 | (2-Methylbutyl)boronic acid | C5H13BO2 | 115.97 | | |
| 444890-41-9 | Mitoquinone | | C37H44O4P | 583.72 | | |
| 444891-21-8 | | tert-butyl 4-(cyano(phenyl)methyl)piperazine-1-carboxylate | | | | |
| 444892-01-7 | (S)-1-Benzyl-3-isobutylpiperazin-2-one | | C15H22N2O | 246.352 | | 409.5±45.0 °C(Predicted) |
| 444892-03-9 | (S)-N4-苄基-2-异丁基哌嗪 | (S)-N4-Benzyl-2-isobutylpiperazine | | | | |
| 444892-51-7 | | 2-(n-boc-piperazino)-2-(4-chlorophenyl)ethylamine | | | | |
| 444892-54-0 | | 1-boc-4-(2-amino-1-phenylethyl)-piperazine | C17H27N3O2 | 305.42 | | 410.3±45.0℃(Predicted) |
| 444892-59-5 | | 2-(4-boc-piperazin-1-yl)-2-(4-cf3-ph)ethanamine | | | | |
| 444892-61-9 | | 2-(n-boc-piperazino)-2-(4-methoxyphenyl)ethylamine | | | | |
| 444892-80-2 | 2-(4-boc-哌嗪)-2-(2-氟苯基)乙酸 | 2-(4-boc-piperazino)-2-(2-fluorophenyl)acetic acid | | | | |
| 444898-79-7 | 6,7-二氟异喹啉-1(2H)-酮 | 6,7-Difluoroisoquinolin-1(2H)-one | C9H5F2NO | 181.14 | | |
| 444898-84-4 | | 8-fluoroisoquinolin-1-ol | C9H6NOF | 163.15 | | |
| 4449-40-5 | 4-氨基-1-((2S,4S,5R)-4-羟基-5-(羟甲基)四氢呋喃-2-基)嘧啶-2(1H)-酮 | 4-Amino-1-((2S,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one | C9H13N3O4 | 227.22 | | |
| 4449-43-8 | | a-thymidine | C10H14N2O5 | 242.23 | | |
m.cnreagent.com